126 related articles for article (PubMed ID: 10746960)
1. An enzyme immunoassay to determine the levels of specific antibodies toward bacterial surface antigens in human immunoglobulin preparations and blood serum.
Lamari F; Anastassiou ED; Tsegenidis T; Dimitracopoulos G; Karamanos NK
J Pharm Biomed Anal; 1999 Sep; 20(6):913-20. PubMed ID: 10746960
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
[TBL] [Abstract][Full Text] [Related]
3. Determination of slime-producing S. epidermidis specific antibodies in human immunoglobulin preparations and blood sera by an enzyme immunoassay: correlation of antibody titers with opsonic activity and application to preterm neonates.
Lamari F; Anastassiou ED; Stamokosta E; Photopoulos S; Xanthou M; Dimitracopoulos G; Karamanos NK
J Pharm Biomed Anal; 2000 Aug; 23(2-3):363-74. PubMed ID: 10933528
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical-based assays in the bioanalysis of immunoglobulins.
Lamari F; Anastassiou ED; Dimitracopoulos G; Karamanos NK
J Pharm Biomed Anal; 2000 Nov; 23(6):939-46. PubMed ID: 11095294
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of the biological activities of IgG in seven Chinese intravenous immunoglobulin preparations.
Ye S; Li D; Liu F; Lei M; Jiang P; Wang Z; Zhang R; Du X; Cao H; Ma L; Li C
J Pharm Biomed Anal; 2018 Mar; 151():317-323. PubMed ID: 29413980
[TBL] [Abstract][Full Text] [Related]
6. Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.
Basma H; Norrby-Teglund A; McGeer A; Low DE; El-Ahmedy O; Dale JB; Schwartz B; Kotb M
Infect Immun; 1998 May; 66(5):2279-83. PubMed ID: 9573118
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
Hiemstra PS; Brands-Tajouiti J; van Furth R
J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of antibodies against β-amyloid 40/42 monomer and oligomers in Chinese intravenous immunoglobulins.
Ye S; Zeng R; Jiang P; Hou M; Liu F; Wang Z; Du X; Yuan J; Chen Y; Cao H; Ma L; Li C
J Pharm Biomed Anal; 2017 May; 138():277-282. PubMed ID: 28231531
[TBL] [Abstract][Full Text] [Related]
9. Analyzing titers of antibodies against bacterial and viral antigens, and bacterial toxoids in the intravenous immunoglobulins utilized in Taiwan.
Wu CY; Wang HC; Wang KT; Yang-Chih Shih D; Lo CF; Wang DY
Biologicals; 2013 Mar; 41(2):88-92. PubMed ID: 23149017
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect and antibody titer of intravenous immunoglobulin (IVIG) against clinical isolates of opportunistic bacteria].
Nakae T; Nakajima T; Nagai H; Watanabe M; Yokoyama K
Yakugaku Zasshi; 1994 Dec; 114(12):972-9. PubMed ID: 7869237
[TBL] [Abstract][Full Text] [Related]
11. Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice.
Dimitriadou MM; Alexopoulos H; Akrivou S; Gola E; Dalakas MC
Neurotherapeutics; 2020 Jan; 17(1):235-242. PubMed ID: 31673865
[TBL] [Abstract][Full Text] [Related]
12. IgG levels against 13-valent pneumococcal conjugate vaccine serotypes in non pneumococcal conjugate vaccine immunized healthy Japanese and intravenous immunoglobulin preparations.
Takahashi Y; Ishiwada N; Hishiki H; Tanaka J; Akeda Y; Shimojo N; Oishi K; Kohno Y
J Infect Chemother; 2014 Dec; 20(12):794-8. PubMed ID: 25242584
[TBL] [Abstract][Full Text] [Related]
13. Commercial Intravenous Immunoglobulin Preparations Contain Functional Neutralizing Antibodies against the Staphylococcus aureus Leukocidin LukAB (LukGH).
Wood JB; Jones LS; Soper NR; Nagarsheth M; Creech CB; Thomsen IP
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874371
[TBL] [Abstract][Full Text] [Related]
14. A direct comparison of the antigen-specific antibody profiles of intravenous immunoglobulins derived from US and UK donor plasma.
Matejtschuk P; Chidwick K; Prince A; More JE; Goldblatt D
Vox Sang; 2002 Jul; 83(1):17-22. PubMed ID: 12100384
[TBL] [Abstract][Full Text] [Related]
15. Treatment potential of pathogen-reactive antibodies sequentially purified from pooled human immunoglobulin.
Reglinski M; Sriskandan S
BMC Res Notes; 2019 Apr; 12(1):228. PubMed ID: 30992057
[TBL] [Abstract][Full Text] [Related]
16. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy.
Norrby-Teglund A; Basma H; Andersson J; McGeer A; Low DE; Kotb M
Clin Infect Dis; 1998 Mar; 26(3):631-8. PubMed ID: 9524835
[TBL] [Abstract][Full Text] [Related]
17. IgG antibody reactive with five serotypes of Streptococcus pneumoniae in commercial intravenous immunoglobulin preparations.
Hamill RJ; Musher DM; Groover JE; Zavell PJ; Watson DA
J Infect Dis; 1992 Jul; 166(1):38-42. PubMed ID: 1607706
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus neutralization by hyperimmune and standard intravenous immunoglobulin preparations.
Planitzer CB; Saemann MD; Gajek H; Farcet MR; Kreil TR
Transplantation; 2011 Aug; 92(3):267-70. PubMed ID: 21659947
[TBL] [Abstract][Full Text] [Related]
19. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations--a potential role for adjuvant intravenous immunoglobulin therapy in infectious diseases.
Krause I; Wu R; Sherer Y; Patanik M; Peter JB; Shoenfeld Y
Transfus Med; 2002 Apr; 12(2):133-9. PubMed ID: 11982967
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of antibacterial and antitoxic activity of normal human immunoglobulin for intravenous use (IVIG)].
Bucholc B; Banach W; Wysokińska T; Cieślik A; Chodorowska M
Med Dosw Mikrobiol; 1996; 48(1-2):87-94. PubMed ID: 8926773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
